BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6248184)

  • 1. Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen.
    Springer GF; Murthy MS; Desai PR; Scanlon EF
    Cancer; 1980 Jun; 45(12):2949-54. PubMed ID: 6248184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human carcinoma-associated precursor antigens of the NM blood group system.
    Springer GF; Desai PR; Murthy MS; Scanlon EF
    J Surg Oncol; 1979; 11(2):95-106. PubMed ID: 220469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed-type skin hypersensitivity reaction (DTH) to Thomsen-Friedenreich (T) antigen as diagnostic test for human breast adenocarcinoma.
    Springer GF; Desai PR; Murthy MS; Scanlon EF
    Klin Wochenschr; 1979 Sep; 57(18):961-3. PubMed ID: 228112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue.
    Springer GF; Desai PR; Banatwala I
    J Natl Cancer Inst; 1975 Feb; 54(2):335-9. PubMed ID: 163330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.
    Springer GF; Murthy SM; Desai PR; Fry WA; Tegtmeyer H; Scanlon EF
    Klin Wochenschr; 1982 Feb; 60(3):121-31. PubMed ID: 6176752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of metastatic breast carcinoma cells by immunofluorescent demonstration of Thomsen-Friedenreich antigen.
    Seitz RC; Fischer K; Stegner HE; Poschmann A
    Cancer; 1984 Sep; 54(5):830-6. PubMed ID: 6331628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
    Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
    J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma-associated cytostructural antigenic alterations: detection by lectin binding.
    Howard DR; Ferguson P; Batsakis JG
    Cancer; 1981 Jun; 47(12):2872-7. PubMed ID: 6167345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to mouse mammary tumor virus-related antigen in sera of patients with breast carcinoma.
    Tomana M; Kajdos AH; Niedermeier W; Durkin WJ; Mestecky J
    Cancer; 1981 Jun; 47(11):2696-703. PubMed ID: 6266639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence and significance of the Thomsen-Friedenreich antigen in breast cancer. I. Serological studies.
    Newman RA; Klein PJ; Uhlenbruck G; Citoler P; Karduck D
    J Cancer Res Clin Oncol; 1979 Feb; 93(2):181-8. PubMed ID: 374421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dialyzable transfer factor in patients with breast cancer.
    Oettgen HF; Old LJ; Farrow JH; Valentine FT; Lawrence HS; Thomas L
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2319-23. PubMed ID: 4366760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22.
    Papsidero LD; Nemoto T; Croghan GA; Chu TM
    Cancer Res; 1984 Oct; 44(10):4653-7. PubMed ID: 6088042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-type cutaneous hypersensitivity to Thomsen-Friedenreich (T) antigen in patients with pancreatic cancer.
    Goodale RL; Springer GF; Shearen JG; Desai PR; Tegtmeyer H
    J Surg Res; 1983 Oct; 35(4):293-7. PubMed ID: 6621025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine mammary tumor virus related antigen in human male mammary carcinoma.
    Lloyd RV; Rosen PP; Sarkar NH; Jimenez D; Kinne DW; Menendez-Botet C; Schwartz MK
    Cancer; 1983 Feb; 51(4):654-61. PubMed ID: 6295611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductular carcinoma of the breast: serum antibodies to tumor-associated antigens.
    Sheikh KM; Quismorio FP; Friou GJ; Lee YT
    Cancer; 1979 Dec; 44(6):2083-9. PubMed ID: 92359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between histology, monoclonal antibody reactivity, and prognosis in breast cancer.
    Yuan D; Dawson PJ
    Hum Pathol; 1987 Nov; 18(11):1097-100. PubMed ID: 2824320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antitumor antibody in normal human serum: reaction of anti-T with breast carcinoma cells.
    Howard DR; Taylor CR
    Oncology; 1980; 37(3):142-8. PubMed ID: 6244524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunity towards Thomsen-Friedenreich antigen in breast-carcinoma patients.
    Springer GF; Murthy MS; Desai PR; Scanlon EF
    Naturwissenschaften; 1976 Jun; 63(6):300. PubMed ID: 967267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.